M.A. Esteve Pastor | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where M.A. Esteve Pastor is active.

Explore More

Publication

Featured researches published by M.A. Esteve Pastor.

European Heart Journal | 2018

4366Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol

M.A. Esteve Pastor; José Miguel Rivera-Caravaca; V. Roldan; E Orenes-Pinero; G F Romiti; I Romanazzi; Y Bai; J Carmo; Marco Proietti; Francisco Marín; Gregory Y.H. Lip

European Heart Journal | 2018

P2905Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry

M.A. Esteve Pastor; I Roldan-Rabadan; José Miguel Rivera-Caravaca; V. Roldan; J Muniz; A. Cequier; V. Bertomeu-Martinez; L Badimon; P Rana-Miguez; M Ruiz-Ortiz; M Anguita; G.Y.H. Lip; Francisco Marín; Fantasiia

European Heart Journal | 2018

P1001Predictors of stroke and overall mortality in real world patients with atrial fibrillation treated with oral anticoagulants

M Anguita; M. Ruiz Ortiz; M.A. Esteve Pastor; Inmaculada Roldán; P. Rana Miguez; Javier Muñiz; Ángel Cequier; Vicente Bertomeu; Lina Badimon; Fátima Marín; Fantasiia Study Investigators

European Heart Journal | 2018

P6240Long term cardiovascular risk prediction in Real-World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry

M.A. Esteve Pastor; José Miguel Rivera-Caravaca; V. Roldan; I Roldan-Rabadan; J Muniz; A. Cequier; V. Bertomeu-Martinez; L Badimon; P Rana-Miguez; M Ruiz-Ortiz; M Anguita; G.Y.H. Lip; Francisco Marín; Fantasiia

European Heart Journal | 2018

P982Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry

M.A. Esteve Pastor; José Miguel Rivera-Caravaca; V. Roldan; I. Roldan Rabadan; Javier Muñiz; A. Cequier; V. Bertomeu-Martinez; Lina Badimon; P Rana-Miguez; M Ruiz-Ortiz; M Anguita; G.Y.H. Lip; Francisco Marín; Fantasiia

European Heart Journal | 2017

5743Clinical determinants of time in therapeutic range and the role of SAMe-TT2R2 score in atrial fibrillation patients receiving oral anticoagulation: data from FANTASIIA registry

M.A. Esteve Pastor; I. Roldan Rabadan; Javier Muñiz; A. Cequier; V. Bertomeu-Martinez; Lina Badimon; P. Rana Miguez; Manuel Anguita; G.Y.H. Lip; Francisco Marín

European Heart Journal | 2017

P5342The 2MACE score predicts cardiovascular events in real-world patients with atrial fibrillation: The FANTASIIA registry

M.A. Esteve Pastor; J. Perez-Copete; J.M. Rivera-Caravaca; V. Roldan; I. Roldan Rabadan; Javier Muñiz; A. Cequier; V. Bertomeu-Martinez; Lina Badimon; P. Rana Miguez; Manuel Anguita; G.Y.H. Lip; Francisco Marín

European Heart Journal | 2017

P5829Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events

V. Roldan; M.A. Esteve Pastor; J.M. Rivera-Caravaca; A. Shantsila; A. Garcia Fernandez; Mariano Valdés; Vicente Vicente; Fátima Marín; G.Y.H. Lip

European Heart Journal | 2017

P4009Temporal trends in the use of antiplatelet therapy in patients with acute coronary syndromes

M.A. Esteve Pastor; Juan M. Ruiz-Nodar; Esteban Orenes-Piñero; José Miguel Rivera-Caravaca; Miriam Quintana-Giner; A. Veliz-Martinez; V. Pernias Escrig; M. Sandin Rollan; N. Vicente Ibarra; M.J. Macias Villanego; E. Candela; L. Carrillo; Teresa Lozano; Mariano Valdés; Fátima Marín

European Heart Journal | 2017